Due to its non-invasive nature, magnetic resonance spectroscopy is a promising tool for investigating neurochemical disease processes, monitoring potential therapy responses, and diagnosis of Alzheimer’s disease (AD). Changes of γ-amino-butyric acid (GABA) and glutamate (Glu) concentrations have been associated with AD, however, their relationship to other disease parameters is still unknown. This work aims to investigate the relationship of GABA and Glu with cognitive measures and demonstrates that the application of Rasch transformation to cognitive assessment data yields more reliable descriptions of cognitive outcome using metabolite concentrations as explanatory variables.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords